Developing new treatments for childhood cancers
Official title: NCI Research Specialist (Clinician Scientist) Award
Funded at Baylor College of Medicine · NIH-11063248 · Data updated 2026-11-12
This study is looking for new and better treatments for kids with solid tumors like neuroblastoma, and it gives young patients a chance to join clinical trials that test these exciting new options while also working to reduce side effects.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | April 1, 2023 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $137,163 |
| NIH project number | 5R50CA275928-03 |
| Project ID | NIH-11063248 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are pediatric patients diagnosed with solid tumors, particularly those with neuroblastoma or relapsed/refractory disease.
✕Less likely to help
Patients with non-solid tumors or those who are not pediatric cancer patients may not benefit from this research.
What this research studies
This research focuses on advancing novel therapies for pediatric patients with solid tumors, particularly neuroblastoma. Led by a Pediatric Hematologist-Oncologist, the project aims to implement early-phase clinical trials that test new treatment options while also addressing the side effects associated with these therapies. The research involves collaboration with national clinical trial networks to ensure comprehensive care and innovative approaches to treatment. Patients may have the opportunity to participate in these trials, contributing to the development of safer and more effective cancer treatments for children.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for children with cancer.
How similar studies have gone: Previous research in pediatric oncology has shown success in developing new therapies through early-phase clinical trials, indicating a promising approach.
Where this research is happening
-
Baylor College of Medicine
Houston, United States Active
Researchers
- Principal investigator: Foster, Jennifer Haunani — Baylor College of Medicine
- Study coordinator: Foster, Jennifer Haunani
Related research
Other NIH-funded projects on the same topics.
-
Multimodal AI to improve genetic diagnosis of congenital heart disease
A new AI tool uses multiple types of patient data to help doctors find genetic causes of congenital heart disease more accurately.
-
Surveillance of Vaccine-Preventable Diseases in Children
This project watches how often common vaccines prevent illnesses in kids who are in the hospital or at the emergency department, and compares them with healthy children getting well-child care.
-
Triple gene therapy approach to heal the heart after a heart attack
A new therapy combines three genetic approaches delivered by a virus to help the heart heal after a heart attack.
-
Thalamic sleep circuit changes in Alzheimer's disease
Aims to understand how sleep-related brain activity in a key sleep regulator called the TRN affects Alzheimer’s progression and whether boosting TRN function could slow symptoms.
-
Cardiomyocyte-fibroblast signaling in atrial fibrillation
A researcher at Baylor College of Medicine is studying how signals between heart muscle cells and supportive heart cells influence atrial fibrillation, with the goal of finding new ways to prevent or treat this common heart rhythm problem.
-
UMPIRE: Keeping Kidneys Healthy for Babies with Spina Bifida
A care protocol for newborns with spina bifida aims to protect kidney function by thoughtful bladder management and monitoring from birth.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.